{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:49:36Z","timestamp":1792511376191,"version":"4.5.0"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"abstract":"<jats:title>This Clinical Report was reaffirmed November 2023.<\/jats:title>\n               <jats:p>Fragile X syndrome (an FMR1\u2013related disorder) is the most commonly inherited form of mental retardation. Early physical recognition is difficult, so boys with developmental delay should be strongly considered for molecular testing. The characteristic adult phenotype usually does not develop until the second decade of life. Girls can also be affected with developmental delay. Because multiple family members can be affected with mental retardation and other conditions (premature ovarian failure and tremor\/ataxia), family history information is of critical importance for the diagnosis and management of affected patients and their families. This report summarizes issues for fragile X syndrome regarding clinical diagnosis, laboratory diagnosis, genetic counseling, related health problems, behavior management, and age-related health supervision guidelines. The diagnosis of fragile X syndrome not only involves the affected children but also potentially has significant health consequences for multiple generations in each family.<\/jats:p>","DOI":"10.1542\/peds.2010-3500","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T22:29:48Z","timestamp":1303770588000},"page":"994-1006","source":"Crossref","is-referenced-by-count":111,"title":["Health Supervision for Children With Fragile X Syndrome"],"prefix":"10.1542","volume":"127","author":[{"given":"Joseph H.","family":"Hersh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Committee on Genetics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2011,5,1]]},"reference":[{"key":"2025100213214439300_B1","unstructured":"Saul\u2008RA, Tarleton\u2008JC. FMR1-related disorders. GeneReviews\u2008[online]. October\u200828, 2010. Available at: www.ncbi.nlm.nih.gov\/books\/NBK1384. Accessed November 18, 2010"},{"key":"2025100213214439300_B2","volume-title":"A Clinical and Genetic Study of 1280 Cases of Mental Defect","author":"Penrose","year":"1938"},{"issue":"3\u20134","key":"2025100213214439300_B3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jnnp.6.3-4.154","article-title":"A pedigree of mental defect showing sex-linkage","volume":"6","author":"Martin","year":"1943","journal-title":"J Neurol Psychiatry"},{"issue":"3","key":"2025100213214439300_B4","first-page":"231","article-title":"A marker X chromosome","volume":"21","author":"Lubs","year":"1969","journal-title":"Am J Hum Genet"},{"key":"2025100213214439300_B5","first-page":"1257","article-title":"The fragile X syndrome","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Warren","year":"2001"},{"key":"2025100213214439300_B6","doi-asserted-by":"crossref","DOI":"10.56021\/9780801868436","volume-title":"Fragile X Syndrome: Diagnosis, Treatment, and Research","author":"Hagerman","year":"2002","edition":"3rd ed."},{"issue":"1","key":"2025100213214439300_B7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1542\/peds.2008-0317","article-title":"Advances in the treatment of fragile X syndrome","volume":"123","author":"Hagerman","year":"2009","journal-title":"Pediatrics"},{"issue":"7","key":"2025100213214439300_B8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci"},{"issue":"7","key":"2025100213214439300_B9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jama.1994.03510310066040","article-title":"Advances in molecular analysis of fragile X syndrome","volume":"271","author":"Warren","year":"1994","journal-title":"JAMA"},{"issue":"2","key":"2025100213214439300_B10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1542\/peds.111.2.407","article-title":"Discovering fragile X syndrome: family experiences and perceptions","volume":"111","author":"Bailey","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"2025100213214439300_B11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.DBP.0000267563.18952.c9","article-title":"The Prader-Willi phenotype of fragile X syndrome","volume":"28","author":"Nowicki","year":"2007","journal-title":"J Dev Behav Pediatr"},{"issue":"2","key":"2025100213214439300_B12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/GIM.0b013e31818de6ee","article-title":"Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature","volume":"11","author":"Hunter","year":"2009","journal-title":"Genet Med"},{"key":"2025100213214439300_B13","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1097\/00004703-200604002-00012","article-title":"Autism spectrum disorders and attention-deficit\/hyperactivity disorder in boys with the fragile X premutation","volume":"27","author":"Farzin","year":"2006","journal-title":"J Dev Behav Pediatr"},{"issue":"4","key":"2025100213214439300_B14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00439-005-1326-8","article-title":"FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure","volume":"117","author":"Bretherick","year":"2005","journal-title":"Hum Genet"},{"issue":"4","key":"2025100213214439300_B15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/humrep\/dei432","article-title":"Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation","volume":"21","author":"Bodega","year":"2006","journal-title":"Hum Reprod"},{"issue":"5","key":"2025100213214439300_B16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.fertnstert.2004.11.059","article-title":"An update: spontaneous premature ovarian failure is not an early menopause","volume":"83","author":"Nelson","year":"2005","journal-title":"Fertil Steril"},{"issue":"6","key":"2025100213214439300_B17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMcp0808697","article-title":"Clinical practice: primary ovarian insufficiency","volume":"360","author":"Nelson","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"2025100213214439300_B18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population","volume":"291","author":"Jacquemont","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"2025100213214439300_B19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/420700","article-title":"Fragile-X-associated tremor\/ataxia syndrome (FXTAS) in females with the FMR1 premutation","volume":"74","author":"Hagerman","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2025100213214439300_B20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.56021\/9780801868436","article-title":"Medical follow-up and pharmacotherapy","volume-title":"Fragile X Syndrome: Diagnosis, Treatment, and Research","author":"Hagerman","year":"2002","edition":"3rd ed."},{"issue":"5","key":"2025100213214439300_B21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00004583-199605000-00014","article-title":"Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic review of 62 cases","volume":"35","author":"Prince","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"2025100213214439300_B22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-079X.1996.tb00286.x","article-title":"Use of melatonin in the treatment of paediatric sleep disorders","volume":"21","author":"Jan","year":"1996","journal-title":"J Pineal Res"},{"issue":"1","key":"2025100213214439300_B23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004703-200602000-00012","article-title":"Lessons from fragile X regarding neurobiology, autism and neurodegeneration","volume":"27","author":"Hagerman","year":"2006","journal-title":"J Dev Behav Pediatr"},{"issue":"6","key":"2025100213214439300_B24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ejhg.2008.61","article-title":"Fragile X syndrome","volume":"16","author":"Garber","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"2025100213214439300_B25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nurt.2010.05.005","article-title":"Fragile X: leading the way for targeted treatments in autism","volume":"7","author":"Wang","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"1","key":"2025100213214439300_B26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.a.10549","article-title":"Biological and environmental contributions to adaptive behavior in fragile X syndrome","volume":"117A","author":"Glaser","year":"2003","journal-title":"Am J Med Genet A"},{"issue":"2","key":"2025100213214439300_B27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ng0693-143","article-title":"The full mutation in the FMR1 gene of male fragile X patients is absent in their sperm","volume":"4","author":"Reyniers","year":"1993","journal-title":"Nat Genet"},{"issue":"33","key":"2025100213214439300_B28","first-page":"740","article-title":"Delayed diagnosis of fragile X syndrome: United States, 1990\u20131999","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2025100213214439300_B29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.GIM.0000086480.69309.1E","article-title":"Screening for fragile X syndrome: parent attitudes and perspectives","volume":"5","author":"Skinner","year":"2003","journal-title":"Genet Med"},{"issue":"3","key":"2025100213214439300_B30","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-0820","article-title":"Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues","volume":"121","author":"Bailey","year":"2008","journal-title":"Pediatrics"},{"issue":"10","key":"2025100213214439300_B31","first-page":"714","article-title":"Fragile X syndrome detection in newborns: pilot study","volume":"10","author":"Saul","year":"2008","journal-title":"Genet Med"},{"issue":"10","key":"2025100213214439300_B32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/GIM.0b013e3181889457","article-title":"Policy considerations in designing a fragile X population screening program","volume":"10","author":"Ross","year":"2008","journal-title":"Genet Med"},{"issue":"6","key":"2025100213214439300_B33","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1542\/peds.2007-2901","article-title":"Recommendations for preventive pediatric health care","volume":"120","author":"American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine, Bright Futures Steering Committee","year":"2007","journal-title":"Pediatrics"},{"key":"2025100213214439300_B34","article-title":"Clinical implications of gray-zone FMR1 alleles [abstract 308]","author":"Sherman"},{"issue":"4","key":"2025100213214439300_B35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1352\/0047-6765(2006)44[283:SAPWID]2.0.CO;2","article-title":"Sexuality and people with intellectual disabilities: assessment of knowledge, attitudes, experiences, and needs","volume":"44","author":"Siebelink","year":"2006","journal-title":"Ment Retard"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/5\/994\/907692\/zpe00511000994.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/5\/994\/907692\/zpe00511000994.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T17:21:54Z","timestamp":1759425714000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/127\/5\/994\/64903\/Health-Supervision-for-Children-With-Fragile-X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,1]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,5,1]]},"published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-3500","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,1]]}}}